Name: Breast cancer 2023
Start: 2023-10-19
End: 2023-10-21
Location: Spain

Conference Information

Welcome Message

Dear All,

It’s our great honour to welcome you all to the "4th World Congress on Breast Cancer and Women’s Health" scheduled during Oct 19-21, 2023 in Webinar.

Breast cancer and women's health are critical areas that have gained significant attention and research in recent years. Breast Cancer 2023 is a platform to unite and collaborate with leading experts, researchers, and healthcare professionals from across the globe to share knowledge and expertise, exchange innovative ideas, and explore the latest advancements in the field.

The congress will provide a unique opportunity to present and discuss new research, therapies, and strategies for the prevention, diagnosis, and treatment of breast cancer and other women's health-related issues. It will be an excellent forum for networking and building collaborative relationships with peers and experts, including academics, clinicians, industry leaders, and policymakers.

The theme of the 4th World Congress on Breast Cancer and Women's Health is "Empowering Women: Uniting for Breast Cancer and Women's Health."

This theme reflects our commitment to promoting and advancing the women's health and well-being of women worldwide while emphasizing the need for interdisciplinary and collaborative efforts to improve the prevention, diagnosis, and treatment of breast cancer and other women's health-related issues.

The congress will feature keynote speeches, plenary sessions, and workshops on various topics, including epidemiology and risk factors of breast cancer, advances in breast cancer treatment, emerging trends in women's health, and innovations in breast cancer research. The congress will also provide opportunities for participants to present their research findings and share their experiences in poster and oral presentations.

In addition to the scientific program, the congress will offer a vibrant social program to enable participants to interact, network, and explore the beautiful city of Valencia, known for its rich cultural heritage, magnificent architecture, and exquisite cuisine.

As organizers, we are committed to providing a safe, inclusive, and welcoming environment for all participants. We will be implementing strict women's health and safety protocols in accordance with the latest guidelines and recommendations from public health authorities to ensure the safety and well-being of all attendees.

We invite you to join us at Breast Cancer 2023 to share your expertise, learn from leading experts, and contribute to advancing research and improving the health and well-being of women worldwide. We look forward to welcoming you to this exciting and transformative event.

Regards,

Organizing Committee,

Breast Cancer 2023

Market Analysis

Breast cancer is a significant public health issue globally, affecting both men and women. The incidence of breast cancer has been increasing, and it is the most common cancer in women worldwide. Market analysis of breast cancer is essential to understand the current and future trends in the breast cancer treatment market. Breast cancer is a major health concern for women worldwide, accounting for the second most common cancer among women after lung cancer. In 2020, an estimated 2.3 million new cases of breast cancer were diagnosed globally, with over 685,000 deaths attributed to the disease. Breast cancer is a complex disease that requires early detection and treatment to improve survival rates and quality of life for patients.

Breast cancer is a global health concern, with approximately 2.3 million cases diagnosed worldwide in 2020. In the United States alone, it is estimated that there will be 281,550 new cases of invasive breast cancer diagnosed in women in 2021. Additionally, there will be an estimated 49,290 new cases of non-invasive (in situ) breast cancer diagnosed in women in the same year. The incidence of breast cancer has been steadily increasing over the past few decades, with an annual growth rate of 0.5% since 2013.

The incidence of breast cancer varies significantly by geographic location. The highest incidence rates are found in developed countries such as the United States, Canada, and Western Europe. Conversely, developing countries such as Africa and South America have lower incidence rates. However, the incidence of breast cancer is increasing in developing countries, particularly in urban areas, due to changes in lifestyle factors such as diet, physical activity, and reproductive behavior.

Advances in technology have played a significant role in the growth of the global breast cancer market. Improved imaging techniques, such as mammography, ultrasound, and magnetic resonance imaging (MRI), have made it possible to detect breast cancer at an earlier stage, leading to better outcomes for patients. Additionally, advances in genetic testing have allowed healthcare providers to identify individuals who are at an increased risk of developing breast cancer due to genetic mutations.

One of the most significant technological advancements in the breast cancer market is the development of targeted therapies. Targeted therapies are drugs that are designed to attack specific cancer cells without harming healthy cells. These therapies have revolutionized breast cancer treatment, allowing for more personalized and effective treatment options for patients.

The treatment options for breast cancer have changed significantly in recent years. In the past, the standard treatment for breast cancer was surgery, followed by chemotherapy or radiation therapy. While surgery is still a primary treatment option for breast cancer, there is now a range of additional treatments available, including targeted therapies, hormonal therapies, and immunotherapies.

Targeted therapies are drugs that are designed to attack specific cancer cells. They work by targeting proteins or other molecules that are present on the surface of cancer cells. Targeted therapies are highly effective in the treatment of breast cancer, particularly in cases where the cancer cells have specific genetic mutations.

Hormonal therapies are drugs that are designed to block the effects of hormones on breast cancer cells. They are most commonly used to treat hormone receptor-positive breast cancers, which account for approximately 70% of all breast cancers. Hormonal therapies are highly effective in reducing the risk of breast cancer recurrence, and they are typically taken for several years after initial treatment.

Immunotherapies are a newer type of breast cancer treatment that works by boosting the body's immune system to attack cancer cells. While still in the early stages of development, immunotherapies have shown promising results in clinical trials, particularly in cases where other treatments have failed.

Global Market Analysis

The global breast cancer market is expected to grow at a CAGR of 10.2% between 2020 and 2027, reaching a value of approximately USD 43.3 billion by 2027. The major drivers of this market growth are the increasing incidence of breast cancer, rising healthcare expenditure, and the development of innovative drugs and therapies for the treatment of breast cancer.

The breast cancer therapeutics market is dominated by targeted therapies such as Herceptin, Perjeta, and Kadcyla. Hormone therapies such as tamoxifen and aromatase inhibitors are also widely used in the treatment of breast cancer. In addition to drug therapy, other treatment options for breast cancer include surgery, radiation therapy, and chemotherapy.

The United States is the largest market for breast cancer treatment, followed by Europe and Asia-Pacific. The Asia-Pacific region is expected to witness the fastest growth in the breast cancer market due to the increasing prevalence of breast cancer in the region, rising healthcare expenditure, and the development of innovative therapies.

Breast cancer is also a significant health issue in Spain, with an estimated 33,000 new cases diagnosed each year. The incidence of breast cancer in Spain has been increasing in recent years, with an annual growth rate of 3.1% between 2000 and 2012. However, the mortality rate for breast cancer in Spain has decreased in recent years, thanks to early detection and improved treatments.

The breast cancer therapeutics market in Spain is expected to grow at a CAGR of 5.6% from 2020 to 2027, reaching a value of approximately USD 772 million by 2027. This growth can be attributed to several factors, including the increased incidence of breast cancer, rising healthcare expenditure, and the development of innovative drugs and therapies for the treatment of breast cancer.

Hormone therapies, such as tamoxifen and aromatase inhibitors, are the most commonly used treatments for breast cancer in Spain. These therapies work by blocking the hormones that fuel the growth of breast cancer cells. Other treatment options for breast cancer in Spain include surgery, radiation therapy, and chemotherapy. In Spain, breast cancer is the most common cancer among women, and the market for breast cancer therapeutics is expected to grow steadily in the coming years. The increasing incidence of breast cancer in Spain highlights the need for continued investment in research and the development of innovative therapies to improve patient outcomes and reduce the burden of breast cancer on society.

Scientific sessions

Track 1- Breast Cancer Biology and Genetics

Breast cancer biology and genetics is a crucial area of research in the field of oncology. Understanding the biology and genetic mechanisms underlying breast cancer is essential for improving prevention, early detection, and treatment strategies.

Studying breast cancer biology and genetics provides crucial insights into the mechanisms driving tumor development, progression, and response to treatment. This knowledge has paved the way for personalized medicine, targeted therapies, and improved patient outcomes, making it an essential area of research in the fight against breast cancer.

Personalized Medicine
Risk Assessment and Prevention
Biomarkers and Prognostic Indicators
Drug Development and Targeted Therapies
Mechanisms of Resistance
Tumor Microenvironment
Preclinical Models

Track 2- Breast Cancer Diagnosis and Imaging

Breast cancer diagnosis and imaging are of paramount importance in the early detection and effective management of breast cancer. Justifying the significance of breast cancer diagnosis and imaging is essential in recognizing its impact on patients' outcomes and healthcare systems.

Breast cancer diagnosis and imaging are vital components of comprehensive breast cancer care. By enabling early detection, guiding treatment decisions, and monitoring patient response, diagnostic imaging plays a central role in improving patient outcomes, reducing mortality rates, and advancing breast cancer research and treatment options.

Early Detection and Improved Prognosis
Minimally Invasive Procedures
Determination of Tumor Characteristics
Assessment of Treatment Response
Monitoring for Recurrence
Risk Assessment and High-Risk Screening
Supporting Research and Clinical Trials
Patient Education and Empowerment

Track 3- Metastatic Breast Cancer and Treatment Advances

Metastatic breast cancer, also known as stage IV breast cancer, is the most advanced stage of the disease, where cancer cells have spread beyond the breast to other parts of the body, such as the bones, liver, lungs, or brain. Justifying the significance of studying metastatic breast cancer and advancing treatment options is crucial in improving patient outcomes and quality of life.

Metastatic breast cancer and advancing treatment options is of utmost importance in addressing the significant challenges posed by this advanced stage of the disease. Through ongoing research and clinical advancements, the goal is to improve patient outcomes, extend survival rates, and enhance the overall quality of life for individuals living with metastatic breast cancer.

High Mortality Rate
Treatment Challenges
Patient-Centered Care
Targeted Therapies and Precision Medicine
Combinatorial Therapies
Clinical Trials and Access to New Therapies
Patient Advocacy and Support

Track 4- Breast cancer staging

Breast cancer staging is an important process that helps to determine the extent and spread of cancer within the body. It is a crucial step in determining the appropriate treatment options for a patient. The staging system should be easy to use and understand for clinicians, as well as provide clear and actionable information for treatment planning. The staging system should accurately predict a patient's likelihood of recurrence or survival, based on their cancer stage. The staging system should be based on sound scientific evidence and validated through clinical trials and studies.

The staging system should be consistent across different populations and should be able to accurately classify patients with different types and stages of breast cancer. The staging system should be relevant to current treatment options and provide guidance on appropriate treatment options based on the cancer stage. Ultimately, the decision to choose a specific breast cancer staging system should be made based on a careful evaluation of these factors, as well as the input and consensus of a multidisciplinary team of healthcare professionals.

Tumor Size (T) and Extent of Spread to Lymph Nodes (N)
Metastasis (M) and Distant Spread
Stage 0 (In Situ Breast Cancer)
Stage I and Stage II Breast Cancer
Stage III and Stage IV Breast Cancer (Metastatic Breast Cancer)
Prognostic Factors and Survival Rates
Staging and Treatment Planning
Clinical and Pathological Staging

Track 5- Immunology and breast cancer

The study of immunology and its role in breast cancer is of great significance in advancing our understanding of tumor behavior and developing novel treatment strategies. Justifying the importance of immunology in breast cancer research is crucial for unlocking the potential of the immune system to fight cancer effectively.

Immunology plays a pivotal role in breast cancer research and treatment. By understanding the interplay between breast cancer cells and the immune system, researchers can develop innovative immunotherapeutic approaches, optimize treatment combinations, and improve patient outcomes in the fight against breast cancer.

Immune System and Tumor Interaction
Immunotherapy Advancements
Biomarkers for Immunotherapy Response
Combination Therapies
Long-Term Survival Benefits
Immunosuppressive Mechanisms in Tumor Microenvironment
Vaccines for Breast Cancer Prevention
Understanding Resistance to Immunotherapy
Immunology-Based Diagnostics

Track 6- Personalized Medicine in Breast Cancer

Personalized medicine in breast cancer is a transformative approach that recognizes the uniqueness of each patient and their tumor biology. By integrating genetic information, molecular profiling, and predictive analytics, personalized medicine empowers healthcare providers to make informed treatment decisions tailored to individual patients. This innovative approach holds the potential to revolutionize breast cancer care, improve treatment outcomes, and pave the way for a more patient-centric and efficient healthcare system.

Personalized medicine, also known as precision medicine, is a revolutionary approach that tailor’s medical treatment to individual patients based on their unique characteristics, such as genetic makeup, lifestyle, and disease profile. In the context of breast cancer, personalized medicine has the potential to transform the management and outcomes of this complex disease.

Genomic Profiling and Tailored Therapies
Predictive Biomarkers and Drug Response
Innovations in Personalized Treatment Plans

Track 7- Screening and Diagnosis for breast cancer

Screening and diagnosis for breast cancer are critical steps in identifying the disease at an early stage, when it is most treatable. In a conference, the decision to choose a specific screening and diagnostic approach for breast cancer is based on several factors. The screening and diagnostic approach should be based on current evidence-based guidelines, which are informed by clinical trials and studies. The approach should be accessible and affordable for all patients, regardless of socioeconomic status or geographic location. The approach should have high sensitivity and specificity, meaning it should be able to detect breast cancer with a high degree of accuracy, while minimizing false positives and false negatives.

Mammography is the most common screening tool used for the early detection of breast cancer. This test uses low-dose X-rays to produce images of the breast tissue, which can be examined for any abnormalities, such as lumps or masses. Mammography is recommended for women who are 50 to 74 years of age, and it is generally recommended every two years. A clinical breast exam is another screening method that involves a healthcare professional examining the breast tissue for any abnormalities, such as lumps or masses.

Breast Cancer Screening Methods
Breast Cancer Screening Guidelines
Diagnostic Procedures for Breast Cancer
Causes of False-Positive and False-Negative Results
Role of Imaging Advances in Diagnosis

Track 8- Breast cancer treatment

Breast cancer is one of the most common types of cancer among women, and effective treatment is essential to improve survival rates and quality of life for patients. Choosing to hold a conference on breast cancer treatment is crucial because it can provide a platform to discuss the latest advances in treatment options and their efficacy in different patient populations. Breast cancer treatment varies depending on the stage and type of cancer, as well as the patient's overall health and individual preferences. Treatment options include surgery, radiation therapy, chemotherapy, targeted therapy, and hormonal therapy. Surgery is the most common treatment for breast cancer and involves removing the tumour and surrounding tissue. The extent of surgery depends on the size and location of the tumour and whether it has spread to nearby lymph nodes.

Chemotherapy involves the use of drugs to kill cancer cells. It may be used after surgery to kill any remaining cancer cells or before surgery to shrink the tumour. The conference can bring together healthcare professionals, researchers, and patient advocates to share their knowledge and experiences in breast cancer treatment. It can also provide an opportunity to discuss the challenges and opportunities in implementing personalized treatment approaches, including genetic testing, targeted therapies, and immunotherapies.

Breast Cancer Treatment Modalities
Multidisciplinary Approach to Treatment
Personalized Treatment and Biomarkers
Advancements in Breast Cancer Treatment
Machine Learning in Breast Cancer

Track 9- Emerging Therapies and Clinical Trials

Emerging therapies and conducting clinical trials are essential in advancing medical knowledge and improving treatment options for breast cancer patients. Researching emerging therapies and conducting clinical trials in breast cancer is crucial for advancing medical science, identifying new treatment options, and improving patient outcomes. By exploring innovative approaches, targeting specific biomarkers, and harnessing the principles of precision medicine, clinical trials provide hope for breast cancer patients while paving the way for a future with more effective and personalized treatments.

Novel Therapeutic Approaches
Resistant Tumor Types
Precision Medicine
Combination Therapies
Patient Access to Innovative Treatments
Regulatory Approval and Standard of Care
Global Collaboration and Research
Optimizing Treatment Sequencing

Track 10-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a distinct subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. Justifying the significance of studying and understanding triple-negative breast cancer is crucial in addressing its unique challenges and developing targeted treatment strategies.

Triple-negative breast cancer is critical for understanding its aggressive nature, identifying potential targets for therapy, and improving treatment outcomes for patients. By delving into the unique biology and challenges of TNBC, researchers can pave the way for innovative therapeutic approaches that may lead to better survival rates and quality of life for those affected by this challenging subtype of breast cancer.

Aggressive Nature and Poor Prognosis
Limited Treatment Options
Identification of Biomarkers and Targets
Immunotherapy Potential
Subtype Heterogeneity
Hereditary and Familial Associations
Clinical Trials and Therapeutic Advancements
Health Equity and Disparities

Track 11- Breast Biopsy

A breast biopsy is a medical procedure performed to determine the presence of abnormal cells or tissue in the breast. It involves removing a small tissue sample from the breast and examining it under a microscope to detect any signs of cancer or other abnormalities. Breast biopsy is a critical diagnostic tool for the detection and diagnosis of breast cancer. Choosing to hold a conference on breast biopsy is essential to promote knowledge sharing and collaboration among healthcare providers, researchers, and patient advocates.

Additionally, a breast biopsy may be recommended to monitor changes in the breast over time. The conference can provide a platform to discuss the latest advances in breast biopsy techniques, including image-guided biopsies, minimally invasive procedures, and molecular testing. It can also highlight the importance of accurate and timely diagnosis in improving outcomes for breast cancer patients. Moreover, the conference can promote the development of standardized protocols and best practices for breast biopsy, ensuring that patients receive high-quality, evidence-based care. It can also promote the importance of patient education and informed consent in the breast biopsy process, ensuring that patients are fully informed about the risks and benefits of the procedure.

Types of Breast Biopsies
Indications for Breast Biopsy
Diagnostic and Screening Biopsies
Preparation and Procedure

Track 12- Radiology

Radiology plays a crucial role in the detection, diagnosis, and treatment of breast cancer. Breast cancer is the most common cancer among women worldwide, and early detection is critical to successful treatment. Radiology techniques such as mammography, ultrasound, and magnetic resonance imaging (MRI) are used to detect and diagnose breast cancer. Radiology plays a crucial role in the detection, diagnosis, and treatment of breast cancer. Choosing to hold a conference on radiology in breast cancer is essential to promote knowledge sharing and collaboration among healthcare providers, researchers, and patient advocates.

Magnetic resonance imaging (MRI) is a highly sensitive radiology technique that is used to detect breast cancer in women at high risk of developing the disease. It uses a magnetic field and radio waves to produce detailed images of the breast tissue, allowing doctors to detect any abnormalities or suspicious lesions The conference can provide a platform to discuss the latest advances in breast imaging techniques, including mammography, ultrasound, MRI, and molecular imaging. It can also highlight the importance of early detection in improving outcomes for breast cancer patients. Moreover, the conference can promote the development of standardized protocols and best practices for breast imaging, ensuring that patients receive high-quality, evidence-based care. It can also promote the importance of patient education and informed consent in the imaging process, ensuring that patients are fully informed about the risks and benefits of the procedure.

Mammography and Early Detection
Diagnostic Imaging Modalities
Biopsy Guidance and Localization
Monitoring Treatment Response
Radiation Exposure and Safety

Track 13- Male breast cancer research

Although breast cancer is more common in women, men can also develop this disease. However, male breast cancer is a relatively rare condition, accounting for less than 1% of all breast cancer cases. Therefore, organizing a conference on male breast cancer research is essential to raise awareness of this disease and promote research efforts to improve outcomes for male breast cancer patients. One major justification for male breast cancer research is the need to improve early detection and diagnosis. Men with breast cancer often face delays in diagnosis, which can lead to more advanced disease at the time of diagnosis and poorer outcomes.

Additionally, male breast cancer tends to be more aggressive than female breast cancer, with a higher rate of lymph node involvement and a higher risk of distant metastases. The conference can provide a platform to discuss the latest research findings on male breast cancer, including its causes, risk factors, and treatment options. It can also highlight the unique challenges facing male breast cancer patients, such as delays in diagnosis and limited access to specialized care.

Epidemiology and Risk Factors
Hormonal and Genetic Factors
Environmental and Lifestyle Factors
Clinical Presentation and Diagnosis
Treatment and Prognosis

Track 14- Chemotherapy for breast cancer

Chemotherapy is an essential component of breast cancer treatment that aims to kill cancer cells and prevent the spread of the disease. Choosing to hold a conference on chemotherapy for breast cancer is essential to promote knowledge sharing and collaboration among healthcare providers, researchers, and patient advocates. Chemotherapy may be recommended for patients with early-stage breast cancer if there is a high risk of recurrence, or for patients with advanced breast cancer that has spread to other parts of the body.

Many different chemotherapy drugs can be used to treat breast cancer, and the specific drugs used will depend on the individual patient's needs and the characteristics of their cancer. The conference can provide a platform to discuss the latest advances in chemotherapy regimens, including new drugs and combinations of drugs. It can also highlight the importance of individualized treatment plans that take into account a patient's specific tumor characteristics and medical history. The conference can promote the development of standardized protocols and best practices for chemotherapy, ensuring that patients receive high-quality, evidence-based care. It can also promote the importance of patient education and informed consent in the treatment process, ensuring that patients are fully informed about the risks and benefits of the treatment.

Chemotherapy Agents and Mechanisms
Chemotherapy Indications and Treatment Planning
Adverse Effects and Supportive Care
Neoadjuvant and Adjuvant Chemotherapy
Resistant Breast Cancer and Novel Approaches

Track 15-Breast Health

Breast health is a crucial aspect of women's overall well-being and plays a pivotal role in breast cancer prevention and early detection. Breast health education empowers women to take charge of their health, fosters early intervention, and reduces the impact of breast cancer on individuals and communities. The promotion of breast health is of paramount importance in improving women's well-being and reducing the burden of breast cancer. Justifying the significance of breast health emphasizes the need for awareness, early detection, and preventive measures.

Health Empowerment and Awareness
Risk Assessment and Personalized Screening
Breast Health in Young Women
Breastfeeding and Breast Health
Health Disparities and Access to Care
Breast Health During Menopause and Aging
Breast Health and Survivorship
Psychosocial Well-being
Breast Health Research and Innovations

Track 16- Artificial Intelligence in Breast Cancer

The integration of AI in breast cancer care holds immense potential to revolutionize how breast cancer is detected, diagnosed, and treated. From improving early detection through advanced imaging analysis to enabling personalized treatment plans based on genetic profiles, AI empowers healthcare providers with powerful tools to enhance patient outcomes and promote precision medicine. Embracing AI in breast cancer care has the potential to significantly impact breast cancer management and research, contributing to better patient experiences and improved survival rates in the fight against breast cancer.

Artificial Intelligence (AI) has emerged as a transformative technology with promising applications in various fields, including healthcare. In breast cancer care, AI is proving to be a powerful tool with the potential to revolutionize early detection, diagnosis, treatment planning, and patient outcomes.

AI in Breast Cancer Screening and Diagnosis
Predictive Models in Patient Outcomes
AI and Big Data in Personalized Medicine
Advancing Breast Cancer Research

Track 17- Maternal Health and Pregnancy

Prioritizing maternal health and pregnancy is crucial for the well-being of expectant mothers, promoting optimal pregnancy outcomes, and reducing maternal and infant mortality. By focusing on prenatal care, mental health support, nutrition, and equitable access to healthcare services, societies can make significant strides in improving maternal health and ensuring healthier pregnancies.

Ensuring maternal health during pregnancy is of utmost importance to promote the well-being of both the expectant mother and her baby. Maternal health encompasses various aspects, including prenatal care, nutrition, mental health, and access to healthcare services.

Optimal Pregnancy Outcomes
Maternal Well-being and Mental Health
Reducing Maternal Mortality and Morbidity
Nutrition and Lifestyle during Pregnancy
Birth Preparedness and Emergency Care
Access to Quality Healthcare Services
Promoting Reproductive Rights and Equity

Track 18- Women Health Issues

Whereas disorders that affect men and women differently may exist, some illnesses are more frequently and specifically felt by women. The majority of drug studies exclude female test volunteers, and many health disorders specific to women go undiagnosed. Contrary to men, more women than men die from heart attacks. Female patients frequently display symptoms of anxiety and depression.

Reproductive Health and Family Planning
Breast Health and Breast Cancer
Mental Health and Well-being
Non-Communicable Diseases (NCDs) and Lifestyle Factors
Sexual and Reproductive Rights

About Conference

It is our great pleasure to invite you to attend the “4th World Congress on Breast Cancer and Women’s Health” which will be held from October 19-21, 2023, in the beautiful city of Webinar.

Breast cancer and women’s health are among the most pressing health issues affecting women worldwide. The congress aims to bring together renowned researchers, experts, clinical oncologists, radiation oncologists, gynaecologists, professors, journalists, scientists, researchers, business professionals, and clinicians from around the globe to discuss the latest research findings, innovative therapies, and emerging trends in the prevention, diagnosis, and treatment of breast cancer and other women’s health-related issues.

The theme of this year’s congress is “Empowering Women: Uniting for Breast Cancer and Women’s Health.”

The congress will focus on interdisciplinary approaches and collaboration to advance research, improve clinical outcomes, and promote health equity for women globally.

The three-day event will feature keynote speeches, plenary sessions, panel discussions, and workshops covering a wide range of topics, including breast cancer epidemiology, risk factors, and prevention; advances in breast cancer treatment; emerging trends in women’s health; and innovations in breast cancer research.

In addition, the congress will provide an excellent opportunity for participants to present their research findings and share their experiences through oral and poster presentations, as well as interact and network with fellow attendees from different parts of the world.

We are committed to providing a safe, inclusive, and welcoming environment for all participants, and we will be implementing all necessary women’s health and safety protocols in accordance with the latest guidelines and recommendations from public health authorities to ensure the safety and well-being of all attendees.

PARTICIPATION OPTIONS

Breast Cancer 2023, provides the participants with different modes or ways to participate under either Academic / Student / Business Category

Keynote speaker: 45-50 minutes
Speaker (workshop): 45-50 minutes
Speaker (oral presentation): 25-30 minutes
Speaker (symposium): more than 45 minutes
Delegate (only registration): will have access to all the sessions with all the benefits of registration
Speaker (special session): 45-50 minutes
Poster presenterate
Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
Remote attendance: can participate via video presentation or e-poster presentation
Media Partner
Sponsor
Collaborator

PARTICIPATION BENEFITS

This Live conference is accredited with CPD credits
Access to all the sessions
Get access to the network with eminent personalities from worldwide
Get worldwide acknowledgement to your profile and Research
Get up to 50% discounts for publishing your entire article in our open access International Journals
Get Handbooks and conference kits
Attend Keynote Presentation by the world’s most eminent researchers
Get OCM certificate
Get Handbooks and conference kits

Who is Eligible to Attend the 2023 Breast Cancer Conferences?

Breast Cancer Specialists, Gynaecology Specialists, Women's Health Surgeons, Gynaecology Oncology Specialists, Breast Cancer radiologists, Breast Cancer Researchers, Healthcare for Women Researchers, Faculty of Health Breast Cancer Medical Schools, Breast Cancer Entrepreneurs and Healthcare Associations, Scientists and professors, Breast Cancer Surgeons, Women's Health Care Researchers, Healthcare Faculty, Registered Nurse, Medical Colleges Staff, Midwife Nurse